Invesco’s Akoya BioSciences AKYA Stock Holding History

Invesco’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,141	Closed	-$62.7K	–	3765
2025 Q1	$62.7K	Buy	+45,141	New	+$98.8K	﹤0.01%	3680

Other funds holding AKYA

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCA

Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Invesco's AKYA Position: Q2 2025 in Review

Invesco sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 45,141 shares — an estimated $62.7K sold.

Invesco first reported a position in AKYA in Q1 2025 and held it in 1 quarter. The position peaked at $62.7K in Q1 2025. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

Invesco reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
Invesco sold 45,141 Akoya BioSciences shares in Q2 2025, an estimated $62.7K.
Invesco first reported a position in Akoya BioSciences in Q1 2025 and held it in 1 quarter.
Invesco's Akoya BioSciences position peaked at $62.7K in Q1 2025.
58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.